1. Home
  2. VTEX vs COLL Comparison

VTEX vs COLL Comparison

Compare VTEX & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTEX
  • COLL
  • Stock Information
  • Founded
  • VTEX 1999
  • COLL 2002
  • Country
  • VTEX Cayman Islands
  • COLL United States
  • Employees
  • VTEX N/A
  • COLL N/A
  • Industry
  • VTEX Computer Software: Prepackaged Software
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTEX Technology
  • COLL Health Care
  • Exchange
  • VTEX Nasdaq
  • COLL Nasdaq
  • Market Cap
  • VTEX 1.2B
  • COLL 958.8M
  • IPO Year
  • VTEX 2021
  • COLL 2015
  • Fundamental
  • Price
  • VTEX $6.42
  • COLL $30.30
  • Analyst Decision
  • VTEX Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • VTEX 4
  • COLL 4
  • Target Price
  • VTEX $8.70
  • COLL $43.75
  • AVG Volume (30 Days)
  • VTEX 1.2M
  • COLL 290.8K
  • Earning Date
  • VTEX 08-05-2025
  • COLL 08-07-2025
  • Dividend Yield
  • VTEX N/A
  • COLL N/A
  • EPS Growth
  • VTEX N/A
  • COLL N/A
  • EPS
  • VTEX 0.07
  • COLL 1.25
  • Revenue
  • VTEX $228,237,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • VTEX $11.66
  • COLL $20.04
  • Revenue Next Year
  • VTEX $16.03
  • COLL $3.98
  • P/E Ratio
  • VTEX $89.21
  • COLL $24.22
  • Revenue Growth
  • VTEX 7.72
  • COLL 17.17
  • 52 Week Low
  • VTEX $4.20
  • COLL $23.23
  • 52 Week High
  • VTEX $8.03
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • VTEX 50.38
  • COLL 58.69
  • Support Level
  • VTEX $6.39
  • COLL $29.28
  • Resistance Level
  • VTEX $6.73
  • COLL $30.17
  • Average True Range (ATR)
  • VTEX 0.22
  • COLL 0.75
  • MACD
  • VTEX -0.04
  • COLL -0.02
  • Stochastic Oscillator
  • VTEX 34.37
  • COLL 69.71

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: